OSE Immunotherapeutics SA (EPA: OSE)

OSE Immunotherapeutics Revenue

OSE Immunotherapeutics had revenue of 82.57M EUR in the half year ending June 30, 2024, with 414.57% growth. This brings the company's revenue in the last twelve months to 83.44M, up 2,209.49% year-over-year. In the year 2023, OSE Immunotherapeutics had annual revenue of 2.23M, down -87.83%.

• Revenue (ttm): 83.44M
• Revenue Growth: +2,209.49%
• P/S Ratio: 2.19
• Revenue / Employee: 1.60M
• Employees: 55
• Market Cap: 188.17M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.23M	-16.08M	-87.83%
Dec 31, 2022	18.30M	-8.00M	-30.43%
Dec 31, 2021	26.31M	15.89M	152.48%
Dec 31, 2020	10.42M	-15.53M	-59.85%
Dec 31, 2019	25.95M	1.50M	6.12%